Asymmetry Capital Management L.P. purchased a new stake in Natera, Inc. (NASDAQ:NTRA) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 63,811 shares of the medical research company’s stock, valued at approximately $693,000. Natera comprises approximately 0.8% of Asymmetry Capital Management L.P.’s portfolio, making the stock its 25th largest holding. Asymmetry Capital Management L.P. owned 0.12% of Natera as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Virtu KCG Holdings LLC bought a new position in shares of Natera in the 2nd quarter valued at $126,000. Los Angeles Capital Management & Equity Research Inc. bought a new position in shares of Natera in the 2nd quarter valued at $151,000. Voya Investment Management LLC lifted its stake in shares of Natera by 17.8% in the 2nd quarter. Voya Investment Management LLC now owns 14,663 shares of the medical research company’s stock valued at $159,000 after acquiring an additional 2,212 shares during the last quarter. American International Group Inc. lifted its stake in shares of Natera by 7.1% in the 1st quarter. American International Group Inc. now owns 16,065 shares of the medical research company’s stock valued at $142,000 after acquiring an additional 1,068 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA lifted its stake in shares of Natera by 1.2% in the 1st quarter. Massachusetts Financial Services Co. MA now owns 16,118 shares of the medical research company’s stock valued at $143,000 after acquiring an additional 194 shares during the last quarter. Institutional investors own 59.79% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Asymmetry Capital Management L.P. Purchases New Position in Natera, Inc. (NTRA)” was originally posted by Daily Political and is the property of of Daily Political. If you are reading this report on another site, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this report can be viewed at https://www.dailypolitical.com/2017/10/12/asymmetry-capital-management-l-p-purchases-new-position-in-natera-inc-ntra.html.

Shares of Natera, Inc. (NTRA) traded up 1.480% on Thursday, reaching $13.375. The company had a trading volume of 58,932 shares. The company’s 50-day moving average is $13.05 and its 200-day moving average is $13.05. Natera, Inc. has a one year low of $7.35 and a one year high of $14.76. The company’s market capitalization is $711.86 million.

Natera (NASDAQ:NTRA) last issued its quarterly earnings data on Tuesday, August 8th. The medical research company reported ($0.52) EPS for the quarter, meeting the consensus estimate of ($0.52). The firm had revenue of $53.60 million during the quarter, compared to the consensus estimate of $50.57 million. Natera had a negative net margin of 62.64% and a negative return on equity of 137.46%. The company’s quarterly revenue was up 3.1% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.46) earnings per share. Equities research analysts predict that Natera, Inc. will post ($2.03) earnings per share for the current year.

In other news, insider Jonathan Sheena sold 120,000 shares of the company’s stock in a transaction dated Wednesday, September 6th. The shares were sold at an average price of $12.54, for a total transaction of $1,504,800.00. Following the completion of the transaction, the insider now directly owns 533,208 shares of the company’s stock, valued at $6,686,428.32. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 12.57% of the company’s stock.

NTRA has been the subject of a number of research reports. ValuEngine cut Natera from a “sell” rating to a “strong sell” rating in a research note on Monday, July 24th. Zacks Investment Research lowered Natera from a “hold” rating to a “sell” rating in a research report on Wednesday, July 12th. BidaskClub lowered Natera from a “hold” rating to a “sell” rating in a research report on Tuesday, August 1st. Morgan Stanley reaffirmed an “overweight” rating and set a $16.00 target price (up from $13.00) on shares of Natera in a research report on Friday, October 6th. Finally, Cowen and Company reaffirmed a “buy” rating and set a $14.00 target price on shares of Natera in a research report on Friday, September 1st. Two investment analysts have rated the stock with a sell rating, one has assigned a hold rating and five have given a buy rating to the company’s stock. Natera has an average rating of “Hold” and a consensus target price of $16.20.

Natera Company Profile

Institutional Ownership by Quarter for Natera (NASDAQ:NTRA)

Receive News & Ratings for Natera Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natera Inc. and related companies with MarketBeat.com's FREE daily email newsletter.